Serratiopeptidase, serratia E-15 protease, serralysin, serratiaprotease, serrapeptase for COVID-19

 Serratiopeptidase, serratia E-15 protease, serralysin, serratiaprotease, serrapeptase has been reported as potentially beneficial for COVID-19 in the following study.
COVID-19 involves the interplay of 350+ viral and host proteins and factors providing many therapeutic targets. Scientists have proposed 10,000+ potential treatments. c19early.org analyzes 200+ treatments. We have not reviewed serratiopeptidase, serratia E-15 protease, serralysin, serratiaprotease, serrapeptase in detail.
Sharma et al., Serratiopeptidase, A Serine Protease Anti-Inflammatory, Fibrinolytic, and Mucolytic Drug, Can Be a Useful Adjuvant for Management in COVID-19, Frontiers in Pharmacology, doi:10.3389/fphar.2021.603997